Cargando…
Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell lines
Dermcidin acts as a survival factor in a variety of cancer cell lines under hypoxia or oxidative stress. The aim of this study was to evaluate dermcidin expression in cell lines following simulation of tumour microenvironmental conditions and in a range of primary tumours. Tumour tissues were collec...
Autores principales: | Stewart, G D, Skipworth, R J E, Pennington, C J, Lowrie, A G, Deans, D A C, Edwards, D R, Habib, F K, Riddick, A C P, Fearon, K C H, Ross, J A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453008/ https://www.ncbi.nlm.nih.gov/pubmed/18594538 http://dx.doi.org/10.1038/sj.bjc.6604458 |
Ejemplares similares
-
Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours
por: Ahlskog, J K J, et al.
Publicado: (2009) -
Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells
por: Roberts, D L, et al.
Publicado: (2009) -
Targeting radiation-resistant hypoxic tumour cells through ATR inhibition
por: Pires, I M, et al.
Publicado: (2012) -
Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells
por: Konecny, G E, et al.
Publicado: (2008) -
Human fucosyltransferase 6 enables prostate cancer metastasis to bone
por: Li, J, et al.
Publicado: (2013)